DARE-HPV
Topline/data readout2027
Stage: Not stated
Public float: $21,339,826 · as of · SEC filing
Topline results are expected in 2027.
8-K · Filed · Last checked
Source details
Alert me · Calendar: same stage and window-end month (2027-12)
Dare Bioscience (DARE) pipeline and stated timing
Name in SEC filings: Dare Bioscience, Inc.
Pipeline at a glance
Source: ORION, orionbiotechai.com/company/DARE, data as of Oct 18, 2026
https://www.orionbiotechai.com/company/DARE
DARE-HPV · Topline/data readout · 2027
SEC sources last checked .
Programs and stated timing
○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.
Matched
Ovaprene
Topline/data readout2027
Stage: Not stated
Public float: $21,339,826 · as of · SEC filing
We currently expect to report topline data from the study in 2027.
10-Q · Filed · Last checked
Source details
Alert me · Calendar: same stage and window-end month (2027-12)
How this date was described over time
Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of .
| Program / event | Stated period and SEC wording | Disclosure in stated period |
|---|---|---|
| DARE-HPVClinical results | 2027“Topline results are expected in 2027.” Filed · EX-99.1 | Period not started The stated period has not started yet, so there is nothing to compare. |
“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.
Watch DARE
Request another SEC timing statement
Suggest an SEC timing statement to add for DARE. You can include the original filing link in your note. The founder reads each request by hand.
Or email ORION.
Reading these records
- First stated window
- The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
- Disclosure date
- The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
- 1H, 2H, 1Q–4Q
- First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
- SEC original
- The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
- Status
- One of seven labels set by founder review of the original filings. Definitions: Methodology.
See DARE in the calendar · Review labels and methodology
Topline results are the main summary results of a clinical trial, released before the full data.